Advancing Rett Care: Translating New Therapeutic Evidence Into Clinical Decision-Making
Please visit answersincme.com/UMW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Jeffrey Neul, MD, PhD. n this activity, an expert in pediatrics and neurology discusses the latest data for treatment of Rett syndrome. Upon completion of this activity, participants should be better able to: Discuss the latest efficacy and safety data for investigational neuroactive pharmacologic therapies in the treatment of RTT; and Translate the latest data into treatment considerations for approved and emerging therapies in RTT.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from CME in Minutes: Education in Primary Care
Beyond the Biomarker: Bridging Patient Voices and Precision Care in HER2-Mutant NSCLC
The Promise of Oral Therapy for HER2-Mutated NSCLC: Unlocking New Treatment Opportunities With a Familiar Target
Managing Type 2 Diabetes Today: Supporting Individualized, Team-Based Care
Expanding the Use of HER2-Directed ADCs Into Early-Stage Breast Cancer: Multidisciplinary Conversations on (Neo)Adjuvant Care
Get summaries like this every morning.
Free AI-powered recaps of CME in Minutes: Education in Primary Care and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.